Inve India ▾

Excel Industries share price & results

Excel Industries Limited· Chemicals· Commodities

Results to
Jun 2026
Latest analysed call
Q4 FY26
Ownership as of
Sept 2026

Phosphorus-chemistry major making agrochemical, specialty & pharma intermediates plus waste management.

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue294 ₹ crore−4.9% YoYQuarterly, as filedQuarter to Jun 2026Revenue from operations as filed.
Operating margin14.0 %0.0 pts YoYOperating profit / revenueQuarter to Jun 2026For the quarter; a change is in percentage points.
Net profit29.0 ₹ crore−14.7% YoYQuarterly, as filedQuarter to Jun 2026Profit after tax as filed.
Return on equity4.25 %−0.3 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow margin-2.19 %−4.0 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)5.47 %−6.4 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Revenue change against the same period one year earlier.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Jun 2026

Guidance

What management said, and what became of it

3 of 4 judged targets kept · 6 open · verdicts reflect calls analysed to Q4 FY26.

Excel Industries Limited management guidance track record on Inve: 10 targets tracked across analysed earnings calls (3 achieved, 1 missed, 6 open).

TargetOriginal wordingSaidLatest callVerdict
Biocide Capacity ExpansionCapacity expansion will come by H2 '26
Call transcript, Q4 FY25 · 16 May 2025		Q4 FY25Q4 FY26:Management confirmed the capacity addition of 2,530 TPA in the biocides range was operational in H2 FY26, fulfilling the promise.
Call transcript, Q4 FY26 · 25 May 2026		Achieved
EBITDA Margin13% to 15% over the medium term
Call transcript, Q4 FY25 · 16 May 2025		Q4 FY25Q4 FY26:Company reported a full-year FY26 adjusted EBITDA margin of 10.1%, missing the guided range of 13-15%.
Call transcript, Q4 FY26 · 25 May 2026		Missed
New Contract Manufacturing LineCommissioned by June 2026 with an estimated investment of Rs 40 crores, generating 35-40 crores annual revenue
Call transcript, Q2 FY26 · 14 Nov 2025		Q2 FY26Q4 FY26:The commissioning timeline has been pushed from June 2026 to July 2026. Project remains on track otherwise.
Call transcript, Q4 FY26 · 25 May 2026		Delayed

Source: Inve Guidance Tracker for Excel Industries Limited · to Q4 FY26

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

1 of Excel Industries Limited's 10 targets was missed. See which ones, and which are quietly gone. The 3 above are the free sample; 7 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.
See the full record

Price

₹866.95 +2.60% · +₹22

Last close 27 Oct 2026 · NSE · INR · Source: Inve

Performance −22.6% 1Y

₹0.8k₹0.9k₹1.0k₹1.1kOct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Oct 26Q2 FY26 — 14 Nov 2025Q4 FY26 — 25 May 2026

1Y: ₹1,119.4 on 24 Oct 2025 → ₹866.95. High ₹1,133.25 (19 Aug 2026), low ₹806.4 (30 Mar 2026).

Previous close
₹844.95
Market cap
₹1.1k Cr
52-week range
₹806.4 – ₹1,133.25
One year
−23.00%
Price to earnings (TTM to Jun 2026)
15.17×
Return on equity (TTM to Jun 2026)
4.25%

Overview

Symbol
NSE:EXCELINDUS
Sector
Chemicals
Industry
Commodities
Exchange
NSE
Currency
INR

What Excel Industries Limited does

Based on the company's own presentations, annual report and earnings calls.

Excel Industries manufactures agrochemical intermediates, specialty phosphorus derivatives, polymer input additives, pharmaceutical intermediates/APIs and veterinary APIs, along with a smaller organic and municipal solid-waste management business. Its chemistry is rooted in phosphorus-based processes (e.g. yellow-phosphorus derivatives) built on decades of backward-integrated, in-house process technology. Products feed end-use industries such as agrochemicals (insecticides/herbicides), water treatment, soaps and detergents, textiles, mining, pharma/veterinary nutrition, paints and coatings, and construction materials. The company also offers contract manufacturing to global customers leveraging its chemical process expertise and manufacturing infrastructure.

Segments

  • Agrochemical Intermediates
  • YP (Yellow Phosphorus) Derivatives
  • Performance Solutions
  • Pharma Intermediates & API
  • Waste Management
Manufacturing locations
3 (Roha, Lote, Vishakhapatnam)
World market position - DETC
No. 1 producer of DETC in the world
World market position - Phosphonates
Top 5 producer of Phosphonates in the world
R&D scientists
31
Unit processes & reactions
19
Process volumes handled
2 million litres
Founded 1941Headquarters Jogeshwari (West), Mumbai, Maharashtra, India Company website

How the price took the results

close before → close after

Q4 FY26
−1.7%
25 May
Q2 FY26
+0.6%
14 Nov

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Your own record

Start an Inve Case for Excel Industries Limited

Free account: one company. Everything above stays public.

Write why you follow Excel Industries Limited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds

Keep reading

Other Chemicals companies

All Chemicals companies → · Chemicals earnings growth →

Learn to analyse Excel Industries Limited

Guides on how to read this kind of business and the numbers that matter.